Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

SHA/603456 stock hub

SHA/603456 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/603456is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

12.1B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/603456

In the news

Latest news · SHA/603456

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.2

P25 17.1P50 24.2P75 37.8

Trailing P/E16.7

P25 23.5P50 41.3P75 83.2

ROE7.3

P25 -0.9P50 4.1P75 8.8

ROIC10.3

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/603456 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

233

Groups with data

Currency

CNY

Showing 233 of 233 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	4,791
Employees Change	-210%
Employees Change Percent	-4.2
Enterprise value	CNY 10.7B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CNE100001W36
Last refreshed	2026-05-10
Market cap	CNY 12.1B
Price	CNY 13.69
Price currency	CNY
Rev Per Employee	1,089,331.6x
Sector	Healthcare
Sic	2833
Symbol	sha/603456

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	5.4%
EV Earnings	16.35x
EV/EBIT	9.95x
EV/EBITDA	7.16x
EV/FCF	10.24x
EV/Sales	1.93x
FCF yield	8.62%
Forward P/E	12.23x
P/B ratio	1.35x
P/E ratio	16.7x
P/S ratio	2.31x
PE Ratio10 Y	47.48x
PE Ratio3 Y	20.56x
PE Ratio5 Y	34.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	18.66%
EBITDA Margin	26.51%
FCF margin	19.93%
Gross margin	33.37%
Gross Profit	CNY 1.7B
Gross Profit Growth	5.89%
Gross Profit Growth Q	-21.69%
Gross Profit Growth3 Y	-4.23%
Gross Profit Growth5 Y	10.23%
Net Income	CNY 652M
Net Income Growth	5.23%
Net Income Growth Q	-31.22%
Net Income Growth Years	1%
Net Income Growth3 Y	-13.12%
Net Income Growth5 Y	8.06%
Pretax Margin	15.88%
Profit Margin	12.49%
Profit Per Employee	CNY 136,079
Profitable Years	18
ROA	5.63
Roa5y	6.74
ROCE	10.6
ROE	7.26
Roe5y	13.07
ROIC	10.26
Roic5y	15.27

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	0.36%
Cagr1y	2.73%
Cagr3y	-21.82%
Cagr5y	-17.82%
Div CAGR10	11.61%
Div CAGR3	7.72%
Div CAGR5	20.11%
EPS Growth	4.49
EPS Growth Q	-32.14
EPS Growth Years	1
EPS Growth3 Y	-14.84
EPS Growth5 Y	6.26
FCF Growth	78.99%
FCF Growth3 Y	26.16%
OCF Growth	18.44%
OCF Growth Q	-52.41%
OCF Growth10 Y	36.87%
OCF Growth3 Y	8.8%
OCF Growth5 Y	38.42%
Revenue Growth	0.85x
Revenue Growth Q	-19.43x
Revenue Growth Years	1x
Revenue Growth3 Y	-3.58x
Revenue Growth5 Y	10.9x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.48
Assets	CNY 10.6B
Cash	CNY 1.6B
Current Assets	CNY 5.4B
Current Liabilities	CNY 1.4B
Debt	CNY 102.1M
Debt EBITDA	CNY 0.07
Debt Equity	CNY 0.01
Debt FCF	CNY 0.1
Equity	CNY 9B
Interest Coverage	96.2
Liabilities	CNY 1.6B
Long Term Assets	CNY 5.2B
Long Term Liabilities	CNY 234.1M
Net Cash	CNY 1.5B
Net Cash By Market Cap	CNY 12.02
Net Cash Growth	-38%
Net Debt EBITDA	CNY -1.05
Net Debt Equity	CNY -0.16
Net Debt FCF	CNY -1.39
Tangible Book Value	CNY 8.4B
Tangible Book Value Per Share	CNY 9.29
WACC	5.9

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.83
Inventory Turnover	2.23
Net Working Capital	CNY 2.5B
Quick ratio	1.89
Working Capital	CNY 4B
Working Capital Turnover	CNY 1.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.71%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	CNY 0.3
Dividend Years	11
Dividend Yield	2.2%
Ex Div Date	2025-09-08
Last Dividend	CNY 0.2
Payout Frequency	Annual
Payout Ratio	69.74%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	3.63%
1Y total return	2.73%
200-day SMA	18.12
3Y total return	-52.22%
50-day SMA	16.41
50-day SMA vs 200-day SMA	50under200
5Y total return	-62.52%
All Time High	63
All Time High Change	-78.27%
All Time High Date	2021-11-29
All Time Low	5.14
All Time Low Change	166.14%
All Time Low Date	2014-10-10
ATR	0.46
Beta	0.3
Ch YTD	-23.52
High	13.74
High52	22.25
High52 Date	2025-11-17
High52ch	-38.47%
Low	13.56
Low52	13.55
Low52 Date	2026-05-06
Low52ch	1.03%
Ma50ch	-16.55%
Price vs 200-day SMA	-24.44%
RSI	25.17
RSI Monthly	36.66
RSI Weekly	29.5
Sharpe ratio	0.16x
Sortino ratio	0.4
Total Return	1.49%
Tr YTD	-23.52
Tr1m	-18.71%
Tr1w	0.66%
Tr3m	-23.43%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 973.9M
Operating Income Growth	23.69
Operating Income Growth Q	-28.35
Operating Income Growth3 Y	-5.22
Operating Income Growth5 Y	12.61
Operating margin	18.66

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	485,760,496%
Net Borrowing	-319,559,363
Shares Insiders	8.15%
Shares Institutions	12.95%
Shares Out	881,710,028
Shares Qo Q	1.63%
Shares Yo Y	0.71%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 1B
Average Volume	17,268,812.9x
Bv Per Share	9.82
CAPEX	CNY -634.2M
Ch10y	-10.65
Ch1m	-18.71
Ch1w	0.66
Ch1y	-0.44
Ch3m	-23.43
Ch3y	-56.08
Ch5y	-65.86
Ch6m	-29.54
Change	0.37%
Change From Open	0.29
Close	13.64
Days Gap	0.07
Depreciation Amortization	409,756,891
Dollar Volume	204,144,198.5
Earnings Date	2026-04-24
EBIT	CNY 973.9M
EBITDA	CNY 1.4B
EPS	CNY 0.73
F Score	7
FCF	CNY 1B
FCF EV Yield	9.76x
FCF Per Share	CNY 1.18
Financing CF	-874,402,706
Fiscal Year End	December
Founded	1,973
Goodwill	12,357,707
Graham Number	12.69564
Graham Upside	-7.26
Income Tax	CNY 181.9M
Investing CF	-1,899,505,096
Is Primary Listing	1
Last Earnings Date	2026-04-24
Last Report Date	2026-03-31
Last Split Date	2018-04-12
Last Split Type	Forward
Lynch Fair Value	CNY 5.88
Lynch Upside	-57.05
Ma150	18.12
Ma150ch	-24.45%
Ma20	15.84
Ma20ch	-13.56%
Net CF	-1,139,041,353
Next Earnings Date	2026-08-06
Open	13.65
P FCF Ratio	11.6
P OCF Ratio	7.21
Payment Date	2025-09-08
Position In Range	72.22
Ppne	4,337,877,322
Price Date	2026-05-08
Price EBITDA	CNY 8.72
Ptbv Ratio	1.43
Relative Volume	0.85x
Revenue	5,218,987,685x
Tax By Revenue	3.48x
Tax Rate	21.94%
Tr6m	-29.54%
Volume	14,911,921

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/603456 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.2%

$0.30 annual per share

Payout ratio

+69.7%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+20.1%

0 consecutive years of growth

Total shareholder yield

+1.5%

Next ex-dividend date: 2025-09-08

Performance

SHA/603456 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/603456?

Insider, institutional, and short-interest positioning.

Institutional ownership

+13.0%

Share of float held by funds and institutions

Insider ownership

+8.1%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.7%

Negative means the company is buying back shares.

Technical

SHA/603456 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

25.2

Below 30: short-term oversold

Price vs 200-day MA

-24.4%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

0.16

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/603456

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/603456 stock rating?

sha/603456 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/603456 analysis?

The full report lives at /stocks/sha/603456/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/603456?

The latest report frames sha/603456 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/603456 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.